BeiGene Market Cap

BeiGene has a market cap or net worth of $27.25 billion as of February 21, 2025. Its market cap has increased by 69.67% in one year.

Market Cap

27.25B

Enterprise Value

25.59B

Revenue

3.35B

Ranking

n/a

PE Ratio

n/a

Stock Price

$15.14

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 27.25B, an increase of 3,073.28%. That is a compound annual growth rate of 46.48%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	27.25B	38.56%
Dec 31, 2024	19.67B	4.69%
Dec 29, 2023	18.79B	-17.76%
Dec 30, 2022	22.84B	-17.96%
Dec 31, 2021	27.84B	18.51%
Dec 31, 2020	23.49B	131.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.16B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	905.51M
Elite Pharmaceuticals	530.93M
Glass House Brands	499.07M
Northwest Biotherapeutics	338.61M
CytoDyn	305.77M

Market Cap Rankings